Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice.

Authors: Li, L  Zhang, H  Verkman, AS 
Citation: Li L, etal., BMC Neurosci. 2009 Aug 6;10:94.
Pubmed: (View Article at PubMed) PMID:19660138
DOI: Full-text: DOI:10.1186/1471-2202-10-94

BACKGROUND: The involvement of astrocyte water channel aquaporin-4 (AQP4) in autoimmune diseases of the central nervous system has been suggested following the identification of AQP4 autoantibodies in neuromyelitis optica, an inflammatory demyelinating disease. RESULTS: We investigated the involvement of AQP4 in disease severity in an established mouse model of experimental autoimmune encephalomyelitis (EAE) produced by immunization with myelin oligodendrocyte glycoprotein (MOG 35-55) peptide. EAE was remarkably attenuated in AQP4 null mice compared to identically treated wildtype mice. Whereas most wildtype mice developed progressive tail and hindlimb paralysis, clinical signs were virtually absent in AQP4 null mice. Brain and spinal cords from AQP1 null mice showed greatly reduced mononuclear cell infiltration compared to wildtype mice, with relatively little myelin loss and axonal degeneration. CONCLUSION: The reduced severity of autoimmune encephalomyelitis in AQP4 deficiency suggests AQP4 as a novel determinant in autoimmune inflammatory diseases of the central nervous system and hence a potential drug target.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 5490116
Created: 2011-09-02
Species: All species
Last Modified: 2011-09-02
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.